News Hub

Apr 30, 2026

Avery Klein

Press Releases

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection

Cocrystal Pharma presented promising progress on CDI-988, an oral direct-acting antiviral targeting norovirus, at ICAR 2026. The Phase 1b human challenge study is fully enrolled in its initial cohort, aiming to establish proof-of-concept for prevention and treatment. CDI-988 targets a conserved protease region across all norovirus strains and coron…

COCP

Apr 30, 2026

Maya Rios

Press Releases

Strata Acquires Ohio Valley Perfusion Associates

Strata Critical Medical, Inc. completed the acquisition of Ohio Valley Perfusion Associates, a regional provider of perfusion services in Ohio and Pennsylvania. The acquisition strengthens Strata's clinical platform in these regions, enabling expansion of services like ECMO support and organ recovery. The purchase aligns with Strata's M&A strategy,…

SRTA

Apr 30, 2026

Maya Rios

Press Releases

LPL Financial Announces First Quarter 2026 Results

LPL Financial Holdings Inc. announced solid financial results for Q1 2026, highlighting a 19% increase in net income to $356 million and a 9% rise in adjusted EPS to $5.60. The company achieved a 30% year-over-year increase in total client assets to $2.3 trillion, with advisory assets growing 42% to $1.4 trillion. Strategic initiatives including pi…

LPLA

Apr 30, 2026

Avery Klein

Press Releases

OrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance

OrthoPediatrics Corp. reported a 13% increase in Q1 2026 revenue to $59.4 million driven by growth in Trauma & Deformity, Scoliosis, and OPSB product lines. Adjusted EBITDA improved to $2.2 million from a loss last year and free cash flow usage decreased 40%. The company raised its 2026 revenue guidance to $263-267 million, expecting 11-13% growth.…

KIDS

Apr 30, 2026

Ajmal Hussain

Press Releases

Stryker reports first quarter 2026 operating results

Stryker Corporation reported a 2.6% increase in net sales to $6.0 billion for Q1 2026, with organic sales rising 2.4%. Reported earnings per share increased 14.2% to $1.93, while adjusted EPS decreased 8.5% to $2.60. The company announced a restructuring combining orthopaedic instruments and other orthopaedics into a new Ortho Tech business to impr…

SYK

Apr 30, 2026

Derek Hwang

Press Releases

SPX Reports First Quarter 2026 Results

SPX Technologies, Inc. reported a robust first quarter for 2026 with revenues up 17.4% to $566.8 million and GAAP income increasing 24.6% to $64.4 million. Adjusted EPS rose 22.5% to $1.69. The company raised its full-year 2026 guidance reflecting strong demand, especially in data center solutions, capacity expansions, and contributions from recent…

SPXC

Apr 30, 2026

Nina Shah

Press Releases

Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Elutia Inc., a Nasdaq-listed biotechnology company specializing in drug-eluting biomatrix technologies for medical devices, will report its first quarter 2026 financial results after market close on May 14, 2026. The company’s management will hold a webcast and conference call to discuss the results.

ELUT

Apr 30, 2026

Derek Hwang

Press Releases

Nyxoah to Participate in the Bank of America 2026 Healthcare Conference

Nyxoah SA announced its participation at the Bank of America 2026 Healthcare Conference where it will present its innovative Genio system, a leadless, battery-free neurostimulation device to treat Obstructive Sleep Apnea (OSA). Nyxoah recently achieved FDA approval for its device in the U.S. and expanded its European CE mark indications, positionin…

NYXH

Apr 30, 2026

Priya Menon

Insider Trading

Nasdaq Executive Bradley Peterson Executes Stock Sale Amid Positive Earnings Momentum

Bradley J. Peterson, who serves as the Executive Vice President and Chief Information Officer at NASDAQ, INC. (NASDAQ:NDAQ), has completed a sale of company shares. The transaction, which took place on April 28, 2026, involved the disposal of 7,710 shares of common stock at a price point of $90.82 per share. This sale resulted in total proceeds of …

Apr 30, 2026

Priya Menon

Insider Trading

Compass Therapeutics Executive Executes Open Market Stock Purchase Amid Recent Volatility

Neil Lerner, the Chief Accounting Officer of Compass Therapeutics, Inc. (NASDAQ: CMPX), has completed an open market purchase of company stock. The transaction, which was corrected via an amended Form 4 filing to accurately reflect the nature of the trade as an open market acquisition, occurred on April 29, 2026. This insider activity comes during …

Apr 30, 2026

Maya Rios

Press Releases

Arhaus to Announce First Quarter 2026 Financial Results on May 7, 2026

Arhaus, Inc., a premium home furnishings company, announced that it will release its first quarter 2026 financial results on May 7, 2026, before the market opens. The company will host a conference call and webcast to discuss the financial and operational results, emphasizing its vertically integrated model and commitment to responsibly sourced, ar…

ARHS

Apr 30, 2026

Jordan Park

Press Releases

NMI Holdings, Inc. Reports First Quarter 2026 Financial Results

NMI Holdings, Inc. reported net income of $99.3 million or $1.28 diluted EPS for Q1 2026, reflecting steady financial performance compared to previous quarters. The company saw growth in primary insurance-in-force to $222.3 billion and increased net premiums earned to $154.8 million. Low loss and expense ratios underscore efficient underwriting and…

NMIH

Apr 30, 2026

Derek Hwang

Press Releases

Brazil Potash Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

Brazil Potash Corp. (NYSE American: GRO), advancing the Autazes potash project in Brazil, has announced a proposed underwritten public offering of common shares and pre-funded warrants to raise capital for working capital and general corporate purposes. The offering specifics, including price and size, will be determined based on market conditions.…

GRO

Apr 30, 2026

Avery Klein

Press Releases

Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion

Alignment Healthcare, Inc. reported strong Q1 2026 financial results with total revenue of $1.24 billion, a 33.3% increase year-over-year, and Medicare Advantage membership growth of 30.9% to approximately 284,800 members. The company improved profitability, delivering net income of $11.4 million compared to a net loss the prior year, and raised th…

ALHC

Apr 30, 2026

Ajmal Hussain

Press Releases

Monolithic Power Systems Reports First Quarter Results on April 30, 2026

Monolithic Power Systems, Inc. reported record quarterly revenue of $804.2 million for Q1 2026, marking a 7.1% increase over Q4 2025 and a 26.1% rise compared to Q1 2025. The company demonstrated strength in its diversified markets, notably with Communications revenue up 33% sequentially and nearly doubling in Enterprise Data year-over-year. Gross …

MPWR

Apr 30, 2026

Avery Klein

Press Releases

Frequency Electronics Inc. Announces Three-Year Revenue Target of At Least $150 Million

Frequency Electronics, Inc. has announced a new minimum revenue target of $150 million by fiscal 2029, reflecting confidence in its expanding backlog and larger end-markets in space and defense technologies. The company anticipates a compound annual growth rate over 30%, driven by advancements in quantum sensing, proliferated satellites, space expl…

FEIM

Apr 30, 2026

Marcus Reed

Press Releases

Ascendis to Report First Quarter 2026 Financial Results and Provide Business Update on May 7, 2026

Ascendis Pharma, a global biopharmaceutical company, announced it will report Q1 2026 financial results and provide a business update on May 7, 2026. The company will host a conference call and webcast to discuss the results and their TransCon technology platform aimed at developing best-in-class therapies addressing unmet medical needs.

ASND

Apr 30, 2026

Jordan Park

Press Releases

Pacira BioSciences Reports First Quarter 2026 Financial Results

Pacira BioSciences reported a 5% revenue increase in Q1 2026 to $177 million, driven by robust sales growth across its commercial portfolio, including a 7% volume increase for EXPAREL. The company completed enrollment in a Phase 3 study for ZILRETTA targeting shoulder osteoarthritis pain, with topline results expected by year-end. Additional real-w…

PCRX

Apr 30, 2026

Caleb Monroe

Press Releases

Xenon to Report Q1 2026 Financial Results on May 7, 2026

Xenon Pharmaceuticals, a neuroscience-focused biopharmaceutical company, announced it will report its Q1 2026 financial results and provide a business update after U.S. market close on May 7, 2026. The company is advancing clinical trials for its lead drug azetukalner and other ion channel modulators targeting epilepsy, depression, and pain.

XENE

Apr 30, 2026

Marcus Reed

Press Releases

Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update

Ardelyx Inc. reported a 38% year-over-year increase in Q1 2026 total product revenue to $93.4 million, driven primarily by a 58% growth in IBSRELA sales. The company reiterated its 2026 full-year revenue guidance and highlighted progress in clinical development, including Phase 3 trials for IBSRELA in chronic idiopathic constipation and ongoing stu…

ARDX

Apr 30, 2026

Marcus Reed

Press Releases

OrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System

OrthoPediatrics Corp. expands its Specialty Bracing portfolio with the introduction of the TRAXIO Complete - Weight System, a mechanical halo gravity traction device designed for pediatric spinal realignment in hospital settings. Developed in collaboration with Synetik Group, the system supports pediatric spine care by offering an adaptable, patien…

KIDS

Apr 30, 2026

Jordan Park

Press Releases

Asure Announces First Quarter 2026 Results

Asure Software announced its first quarter 2026 results demonstrating a 23% year-over-year revenue increase to $42.8 million and net income of $0.6 million compared to a prior year net loss. Adjusted EBITDA rose 69% to $12.3 million, reflecting improved profitability and operational efficiency. The company is investing strategically in sales, marke…

ASUR

Apr 30, 2026

Nina Shah

Press Releases

Syndax Reports First Quarter 2026 Financial Results and Provides Business Update

Syndax Pharmaceuticals reported a 224% year-over-year increase in total revenue to $64.9 million in Q1 2026 driven by strong sales of Revuforj and Niktimvo. The company highlighted leadership in menin inhibition with revumenib (Revuforj) and continued growth of Niktimvo's collaboration revenue. Syndax anticipates key data releases in 2026 including…

SNDX

Apr 30, 2026

Sofia Navarro

Press Releases

Casella Waste Systems, Inc. Announces First Quarter 2026 Results; Updates Fiscal Year 2026 Guidance

Casella Waste Systems, Inc. released its Q1 2026 financial results showing a 9.6% increase in revenues to $457.3 million, driven by acquisitions and solid waste pricing growth. Adjusted EBITDA increased 12.3% to $97.1 million, and the company raised its full-year 2026 guidance for revenues, Adjusted EBITDA, and Adjusted Free Cash Flow, reflecting c…

CWST

Apr 30, 2026

Leila Farooq

Press Releases

NewtekOne, Inc. Reports 1Q26 Basic and Diluted EPS of $0.43

NewtekOne, Inc. (Nasdaq: NEWT) announced its financial results for Q1 2026, highlighting a 19.4% increase in basic EPS to $0.43 from $0.36 in Q1 2025. Key performance metrics such as return on average assets (1.96%) and return on tangible common equity (14.8%) improved year-over-year. The company reported robust deposit growth, nearly doubling year…

NEWT